146 related articles for article (PubMed ID: 26795951)
1. Study of Arsenic Sulfide in Solid Tumor Cells Reveals Regulation of Nuclear Factors of Activated T-cells by PML and p53.
Ding W; Tong Y; Zhang X; Pan M; Chen S
Sci Rep; 2016 Jan; 6():19793. PubMed ID: 26795951
[TBL] [Abstract][Full Text] [Related]
2. Arsenic sulfide induces RAG1-dependent DNA damage for cell killing by inhibiting NFATc3 in gastric cancer cells.
Kang T; Ge M; Wang R; Tan Z; Zhang X; Zhu C; Liu H; Chen S
J Exp Clin Cancer Res; 2019 Dec; 38(1):487. PubMed ID: 31822296
[TBL] [Abstract][Full Text] [Related]
3. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
[TBL] [Abstract][Full Text] [Related]
4. Nuclear factor of activated T-cell c3 inhibition of mammalian target of rapamycin signaling through induction of regulated in development and DNA damage response 1 in human intestinal cells.
Zhou Y; Wang Q; Guo Z; Weiss HL; Evers BM
Mol Biol Cell; 2012 Aug; 23(15):2963-72. PubMed ID: 22696685
[TBL] [Abstract][Full Text] [Related]
5. High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.
Lee HL; Bae OY; Baek KH; Kwon A; Hwang HR; Qadir AS; Park HJ; Woo KM; Ryoo HM; Baek JH
Bone; 2011 Aug; 49(2):242-9. PubMed ID: 21514407
[TBL] [Abstract][Full Text] [Related]
6. The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
Kawahara T; Kashiwagi E; Ide H; Li Y; Zheng Y; Ishiguro H; Miyamoto H
Prostate; 2015 May; 75(6):573-84. PubMed ID: 25631176
[TBL] [Abstract][Full Text] [Related]
7. Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF-7.
Bao-Lei T; Zhu-Zhong M; Yi S; Jun-Jie Q; Yan D; Hua L; Bin L; Guo-Wei Z; Zhi-Xian S
J Cell Biochem; 2006 Feb; 97(3):561-71. PubMed ID: 16215989
[TBL] [Abstract][Full Text] [Related]
8. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
9. NFATc3 mediates the sensitivity of gastric cancer cells to arsenic sulfide.
Zhang X; Kang T; Zhang L; Tong Y; Ding W; Chen S
Oncotarget; 2017 Aug; 8(32):52735-52745. PubMed ID: 28881766
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor of activated T cells (NFAT) signaling regulates PTEN expression and intestinal cell differentiation.
Wang Q; Zhou Y; Jackson LN; Johnson SM; Chow CW; Evers BM
Mol Biol Cell; 2011 Feb; 22(3):412-20. PubMed ID: 21148296
[TBL] [Abstract][Full Text] [Related]
11. Arsenic sulfide, the main component of realgar, a traditional Chinese medicine, induces apoptosis of gastric cancer cells in vitro and in vivo.
Zhang L; Tian W; Kim S; Ding W; Tong Y; Chen S
Drug Des Devel Ther; 2015; 9():79-92. PubMed ID: 25565771
[TBL] [Abstract][Full Text] [Related]
12. Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Zhang L; Tong Y; Zhang X; Pan M; Chen S
Drug Des Devel Ther; 2015; 9():5851-62. PubMed ID: 26586936
[TBL] [Abstract][Full Text] [Related]
13. Promyelocytic leukemia protein is required for gain of function by mutant p53.
Haupt S; di Agostino S; Mizrahi I; Alsheich-Bartok O; Voorhoeve M; Damalas A; Blandino G; Haupt Y
Cancer Res; 2009 Jun; 69(11):4818-26. PubMed ID: 19487292
[TBL] [Abstract][Full Text] [Related]
14. Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis.
Kawahara T; Kashiwagi E; Li Y; Zheng Y; Miyamoto Y; Netto GJ; Ishiguro H; Miyamoto H
Mol Carcinog; 2016 Feb; 55(2):161-9. PubMed ID: 25594762
[TBL] [Abstract][Full Text] [Related]
15. Direct transcriptional activation of promyelocytic leukemia protein by IFN regulatory factor 3 induces the p53-dependent growth inhibition of cancer cells.
Kim TK; Lee JS; Oh SY; Jin X; Choi YJ; Lee TH; Lee Eh; Choi YK; You S; Chung YG; Lee JB; DePinho RA; Chin L; Kim H
Cancer Res; 2007 Dec; 67(23):11133-40. PubMed ID: 18056437
[TBL] [Abstract][Full Text] [Related]
16. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
17. Nuclear factor of activated T-cells (NFAT)C2 inhibits Notch receptor signaling in osteoblasts.
Zanotti S; Smerdel-Ramoya A; Canalis E
J Biol Chem; 2013 Jan; 288(1):624-32. PubMed ID: 23166323
[TBL] [Abstract][Full Text] [Related]
18. DDX3 loss by p53 inactivation promotes tumor malignancy via the MDM2/Slug/E-cadherin pathway and poor patient outcome in non-small-cell lung cancer.
Wu DW; Lee MC; Wang J; Chen CY; Cheng YW; Lee H
Oncogene; 2014 Mar; 33(12):1515-26. PubMed ID: 23584477
[TBL] [Abstract][Full Text] [Related]
19. Control of neuronal apoptosis by reciprocal regulation of NFATc3 and Trim17.
Mojsa B; Mora S; Bossowski JP; Lassot I; Desagher S
Cell Death Differ; 2015 Feb; 22(2):274-86. PubMed ID: 25215946
[TBL] [Abstract][Full Text] [Related]
20. PML enhances the regulation of p53 by CK1 in response to DNA damage.
Alsheich-Bartok O; Haupt S; Alkalay-Snir I; Saito S; Appella E; Haupt Y
Oncogene; 2008 Jun; 27(26):3653-61. PubMed ID: 18246126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
